神经重症监护病房患者经颅超声评估第三脑室检测脑积水的诊断可靠性初步研究
该前瞻性研究在16张床位的神经重症监护病房纳入100例需要脑CT和经颅超声监测的连续脑损伤成人患者,盲法测量第三脑室直径,比较经颅超声与脑CT(金标准)的一致性和诊断效能,并评估住院医师的学习曲线。结果显示,第三脑室直径可在87例(87%)患者至少一侧颅骨测得,70例(70%)双侧颞窗均可用;经颅超声与脑CT的ICC右侧为0.90 [95% CI 0.84-0.93],左侧为0.92 [0.88-0.95];Bland-Altman分析右侧平均差0.36、标准差1.52、95%一致性界限-2.7至3.3 mm,左侧平均差0.25、标准差1.47、95%一致性界限-2.7至3.1 mm。在87例可评估患者中,经颅超声排除脑积水35例(40%)、确认25例(29%)、不确定27例(31%);35例脑积水患者中31例(89%)至少一侧可测得第三脑室直径。住院医师完成5次测量后,每人均达到与专家操作者满意的测量一致性。作者认为,经颅超声可快速、简单、可靠地测量第三脑室直径,可能有助于更早发现临床隐匿性脑积水,但需进一步研究评估其潜在临床获益。
要点
- 在神经重症监护病房脑损伤成人患者中,经颅超声测量第三脑室直径与脑CT一致性良好:ICC右侧0.90 [95% CI 0.84-0.93],左侧0.92 [0.88-0.95]。
- 87例(87%)患者至少一侧颅骨可测得第三脑室直径,70例(70%)双侧颞窗均可用,提示约13%患者无法评估。
- 在87例可评估患者中,经颅超声排除脑积水35例(40%)、确认25例(29%)、不确定27例(31%)。
- 35例脑积水患者中31例(89%)至少一侧可测得第三脑室直径,提示经颅超声在脑积水患者中多数可评估。
- 住院医师完成5次测量后,每人均达到与专家操作者满意的测量一致性,提示学习曲线较短。
适用人群与场景
- 学术医院16张床位的神经重症监护病房中,连续纳入的需要脑CT和经颅超声监测的脑损伤成人患者。
诊断标准与关键阈值
- 以脑CT为金标准测量第三脑室直径,经颅超声盲法测量第三脑室直径与之比较。
处置流程与药物剂量
- 经颅超声从至少一侧颞窗测量第三脑室直径,与脑CT测量值进行比较;住院医师连续测量以评估学习曲线,完成5次测量后达到与专家操作者满意的一致性。
研究设计与关键结果
- 前瞻性研究纳入100例患者,第三脑室直径可在87例(87%)患者至少一侧颅骨测得,70例(70%)双侧颞窗均可用。
- 经颅超声与脑CT测量第三脑室直径的ICC右侧0.90 [95% CI 0.84-0.93],左侧0.92 [0.88-0.95]。
- Bland-Altman分析右侧平均差0.36、标准差1.52、95%一致性界限-2.7至3.3 mm;左侧平均差0.25、标准差1.47、95%一致性界限-2.7至3.1 mm。
- 35例脑积水患者中,31例(89%)至少一侧可测得第三脑室直径;87例可评估患者中,经颅超声排除脑积水35例(40%)、确认25例(29%)、不确定27例(31%)。
- 住院医师完成5次测量后,每人均达到与专家操作者满意的测量一致性。
证据类型、等级与局限
- 前瞻性诊断可靠性初步研究,单中心(16张床位的神经重症监护病房),样本量100例。
- 局限:原文报告需进一步研究以评估该方法的潜在临床获益。
对床旁实践的改变
- 作者认为,经颅超声可快速、简单、可靠地测量第三脑室直径,除避免辐射性操作和转运至放射科外,可能尤其有助于增加密切患者监测以更早发现临床隐匿性脑积水;作者指出需进一步研究评估该方法的潜在临床获益。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Transcranial sonography is a point-of-care tool recommended in intensive care units (ICU) to monitor brain injured patients. Objectives of the study was to assess feasibility and reliability of the third ventricle (V3) diameter measurement using transcranial sonography (TCS) compared to brain computed-tomography (CT), the gold standard measurement, and to measure the TCS learning curve.
DESIGN: prospective study, in a 16-bed neurological ICU in an academic hospital. Every consecutive brain injured adult patient, who required a brain CT and TCS monitoring were included. The V3 diameter was blindly measured by TCS and CT. Intraclass correlation coefficient (ICC) and Bland-Altman plot were used to assess the reliability and agreement between TCS and CT V3 measurements. Diagnosis performance of the V3 diameter using TCS to detect hydrocephalus was measured. Absolute difference between V3 measurement by residents and experts was measured consecutively to assess the learning curve.
RESULTS: Among the 100 patients included in the study, V3 diameter could be assessed in 87 patients (87%) from at least one side of the skull. Both temporal windows were available in 70 patients (70%). The ICC between V3 diameter measured by TCS and CT was 0.90 [95% CI 0.84-0.93] on the right side, and 0.92 [0.88-0.95] on the left side. In Bland-Altman analysis, mean difference, standard deviation, 95% limits of agreement were 0.36, 1.52, - 2.7 to 3.3 mm, respectively, on the right side; 0.25, 1.47, - 2.7 to 3.1 mm, respectively, on the left side. Among the 35 patients with hydrocephalus, V3 diameters could be measured by TCS in 31 patients (89%) from at least one side. Hydrocephalus was, respectively, excluded, confirmed, or inconclusive using TCS in 35 (40%), 25 (29%) and 27 (31%) of the 87 assessable patients. After 5 measurements, every resident reached a satisfactory measurement compared to the expert operator.
CONCLUSION: TCS allows rapid, simple and reliable V3 diameter measurement compared with the gold standard in neuro-ICU patients. Aside from sparing irradiating procedures and transfers to the radiology department, it may especially increase close patient monitoring to detect clinically occult hydrocephalus earlier. Further studies are needed to measure the potential clinical benefit of this method.
TRIAL REGISTRATION: ClinicalTrials.gov ID: NCT02830269.
参考来源
- Widehem R, Bory P, Greco F, et al. Transcranial sonographic assessment of the third ventricle in neuro-ICU patients to detect hydrocephalus: a diagnostic reliability pilot study. Ann Intensive Care. 2021. PMID: 33945045. doi:10.1186/s13613-021-00857-x
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。